SAPHMIRATE-T50 Butamirate Citrate 50mg Sustained Release Tablet 1's
SAPHMIR-ZARFGQ
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications
Symptomatic treatment of acute cough of any origin. Used for cough sedation before and after operation.
Dosage
Adult: As 50 mg tab: 2 or 3 tabs daily at intervals of 8 or 12 hours. As 7.5 mg/5 mL syr: 22.5 mg (15 mL) up to 4 times daily. Max: 90 mg (60 mL) daily.
Administration
Administer with or without food.
Contraindications
Hypersensitivity to any component of the formulation. Refer to manufacturer labeling for further detail.
Pregnancy Interactions
Contraindicated: 1st trimester of pregnancy
Special Precautions
Hepatic and renal impairment. Pregnancy and lactation.
Storage
Store below 30°C.
MedsGo Class
Cough & Cold Preparations
Features
Brand
SAPHMIRATE-T50
Full Details
Dosage Strength
50mg
Drug Ingredients
- Butamirate Citrate
Drug Packaging
Sustained Release Tablet 1's
Generic Name
Butamirate Citrate
Dosage Form
Sustained Release Tablet
Registration Number
DRP-9828
Drug Classification
Over-The-Counter (OTC)
Please sign in so that we can notify you about a reply